Summary
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in adults with chronic hepatitis C virus infection.
Register to download
PRA Exceeds Tough Enrollment Goals
You may also be interested in:
Case Study
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
View Resource
page
Therapeutic Expertise
Read More
Blog
Ask the Experts: What Does the World Need to Know About TB?
According to the World Health Organization, Tuberculosis (TB) is the world’s leading infectious cause of death. Despite significant advances in…
Read Story
View all related content and resources for Infectious Diseases
Explore Insights